Table 1. Injection data and comparison of ECFP mutation by adult and embryo injections.
Injection Mix | G-1 | G0 Fluorescence Phenotype | G1 Fluorescence Phenotype | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein | sgECFP | Saponin | G-1 Cross | No. Injected | Injection time PBM (hours) | No. on EC day | No. | Cyan+ | Cyan- | Cyan- | Cyan Mosaic | G0 C+R+ Outcross | No. | Cyan+ | Cyan- | Cyan- |
DsRed+ | DsRed- | DsRed+ | DsRed+ | DsRed+ | DsRed- | DsRed+ | ||||||||||
Adult injections: P2C-Cas9/gRNA mix injections into VgCp26.10 colony females (G-1) crossed with wild type males | ||||||||||||||||
0.5 µg/µL | 0.75 µg/µL | + | VgCp26.10 Females X WT Males | 300 | 24 | 212 | 425 | 106 | 317 | 2 (0.47%) | 0 | Female | 295 | 103 | 192 | 0 |
Male | 622 | 324 | 298 | 0 | ||||||||||||
0.75 µg/µL | 1.2 µg/µL | + | VgCp26.10 Females X WT Males | 83 | 48 | 60 | 194 | 160 | 24 | 10 (5.2%) | 1* (1.2%) | Female | 52 | 26 | 26 | 0 |
Male | 102 | 38 | 53 | 11 (10.8%) | ||||||||||||
0.75 µg/µL | 1.2 µg/µL | + | VgCp26.10 Females X WT Males | 63 | 47 | 33 | 161 | 52 | 107 | 2 (1.2%) | 1** (0.62%) | Female | 61 | 29 | 32 | 0 |
Male | 84 | 35 | 49 | 0 | ||||||||||||
0.75 µg/µL | 1.2 µg/µL | + | VgCp26.10 Females X WT Males | 78 | 46 | 46 | 71 | 41 | 30 | 0 | 2** (2.8%) | Female | 113 | 30 | 83 | 0 |
Male | ND | |||||||||||||||
Sap+ Totals: | 524 | 351 | 851 | 359 | 478 | 14 (1.7%) | 4 (0.47%) | 1329 | 585 | 733 | 11 (0.82%) | |||||
0.75 µg/µL | 1.1 µg/µL | — | VgCp26.10 Females X WT Males | 97 | 28 | 78 | 184 | 114 | 70 | 0 | 0 | Female | 217 | 96 | 118 | 3 (1.4%) |
Male | 97 | 49 | 48 | 0 | ||||||||||||
0.75 µg/µL | 1.1 µg/µL | — | VgCp26.10 Females X WT Males | 71 | 25 | 43 | 173 | 61 | 112 | 0 | 0 | Female | 41 | 15 | 26 | 0 |
Male | 207 | 109 | 98 | 0 | ||||||||||||
Sap - Totals: | 168 | 121 | 357 | 175 | 182 | 0 | 0 | 562 | 269 | 290 | 3 (0.53%) | |||||
Totals: | 692 | 472 | 1208 | 534 | 660 | 0 | 0 | 1891 | 854 | 1023 | 14 (0.74%) | |||||
Embryo injections: Cas9/gRNA mix injections into homozygous VgCp26.10 transgenic embryos (G0) | ||||||||||||||||
0.2 µg/µL | 0.075 µg/µL | — | VgCp26.10 Intercross | 309 | Not Screened | 2320 | 2317 | 3 (0.13%) | 0 | |||||||
0.2 µg/µL | 0.3 µg/µL | — | VgCp26.10 Intercross | 382 | Not Screened | 5646 | 5506 | 52 (0.92%) | 88 (1.5%) | |||||||
Totals: | 691 | 7966 | 7823 | 55 (0.69%) | 88 (1.1%) |
individual had one cyan+ eye and one cyan- eye.
these individuals had markedly reduced cyan fluorescence.